Pricing Log in Create free account

Lucid Diagnostics Inc. (LUCD) vs Nyxoah SA (NYXH)

Lucid Diagnostics Inc. and Nyxoah SA are both Medical Devices companies. Lucid Diagnostics Inc. and Nyxoah SA are of similar size ($82.6M and $79.3M). Nyxoah SA grew revenue faster over the last twelve months: 366.2% against 24.9%. Nyxoah SA has the higher net margin (−446.4% vs −1,193.9%) and the higher return on invested capital (−117.8% vs −3,096.5%). Across the 17 metrics below, Nyxoah SA leads on 13 and Lucid Diagnostics Inc. on 4.

Valuation

Metric LUCD NYXH Medical Devices median
P/E n/m n/m 25.58
P/S 13.12 1.84 2.54
P/B 6.54 0.48 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 11.30 0.06 2.72
Earnings yield (120.51%) (311.11%) (12.82%)
Free cash flow yield (66.07%) (187.33%) (8.18%)

Profitability

Metric LUCD NYXH Medical Devices median
Gross margin (21.69%) 60.16% 57.76%
Operating margin (930.84%) (391.25%) (15.07%)
Net margin (1,193.87%) (446.39%) (14.45%)
Free cash flow margin (866.56%) (344.99%) (3.88%)
Return on equity 364.89% (124.41%) (10.35%)
Return on assets (167.51%) (68.23%) (17.26%)
Return on invested capital (3,096.53%) (117.82%) (5.27%)

Growth

Metric LUCD NYXH Medical Devices median
Revenue growth (TTM) 24.89% 366.24% 10.41%
EPS growth (last fiscal year) 34.29% (36.22%) 28.17%
Revenue growth, 5-year CAGR — 170.14% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LUCD NYXH Medical Devices median
Debt to equity 2.15 0.72 0.04
Current ratio 1.33 2.38 2.74
Net debt to EBITDA 0.22 0.08 0.54

Dividend

Metric LUCD NYXH Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric LUCD NYXH Medical Devices median
Market cap 79.28m 82.59m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack